Viewing Study NCT06167694


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-06 @ 1:55 AM
Study NCT ID: NCT06167694
Status: RECRUITING
Last Update Posted: 2023-12-22
First Post: 2023-12-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable or Metastatic Breast Cancer View
Keywords: